Farther Finance Advisors
MTNB icon

Farther Finance Advisors’s Matinas BioPharma MTNB Stock Holding History

Farther Finance Advisors’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Hold
0
– -$3 – 6272
2026
Q2 		– Hold
0
– – – 5955
2026
Q1 		– Sell
-28
Closed -$263 – 5727
2025
Q4 		$247 Hold
28
– – ﹤0.01% 5177
2025
Q3 		$798 Buy
+28
New +$604 ﹤0.01% 4436
2025
Q2 		– Hold
0
– – – 4471
2025
Q1 		– Hold
0
– – – 4242

Farther Finance Advisors's MTNB Position: Q3 2026 in Review

Farther Finance Advisors held its Matinas BioPharma (MTNB) position steady in Q3 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6272.

Farther Finance Advisors first reported a position in MTNB in Q3 2025 and has held it in 2 quarters since. The position peaked at $798 in Q3 2025. 0 funds tracked by Wall St. Rank hold MTNB as of Q3 2026.

  • Farther Finance Advisors held 0 shares of Matinas BioPharma worth $0 as of Q3 2026.
  • Farther Finance Advisors left its Matinas BioPharma share count unchanged in Q3 2026.
  • Matinas BioPharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #6272 holding.
  • Farther Finance Advisors first reported a position in Matinas BioPharma in Q3 2025 and has held it in 2 quarters since.
  • Farther Finance Advisors's Matinas BioPharma position peaked at $798 in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.